Rob Telson
Rob Telson brings over 25 years of sales expertise in licensing intellectual property and selling EDA technology across multiple vertical markets. He has had success developing sales and support organizations at small, midsize, and large companies. At ARM, a global semiconductor and software design company, Rob was Vice President of Foundry Sales worldwide and prior was Vice President of Sales for the Americas. At Synopsys, he was responsible for building and developing a business focused on disruptive technologies in the semiconductor space. Rob has been impactful on driving the growth and demand of BrainChip’s technology leading Worldwide Sales and Marketing and now developing and leading the Ecosystem and Partnerships at BrainChip. Rob holds a BS in political science from the University of Arizona and a Program for Leadership Development certificate from Harvard Business School.
Sabrina Martucci Johnson
Sabrina Martucci Johnson is a life sciences executive with a record of achievement in building successful companies, launching innovative products into specialty markets, delivering returns on shareholder investments, and implementing complex directional change.
Sabrina is committed to advancing innovation in women’s health. She is the Founder and CEO of DARÉ Bioscience (NASDAQ:DARE), a clinical-stage biopharmaceutical company driven by a mission to identify, develop and bring to market a diverse portfolio of novel therapies that expand treatment options, improve outcomes and facilitate convenience for women. Prior to founding DARÉ, Sabrina was President of WomanCare Global Trading, a global provider of women’s health products, CFO/CAO of the California Institute for Biomedical Research, CFO/COO of Cypress Bioscience, Inc. (NASDAQ:CYPB), held marketing and sales positions with Advanced Tissue Sciences, and began her career in the biotechnology industry as a research scientist with Baxter Healthcare, Hyland Division, working on the recombinant factor VIII program.
Sabrina has a Master of International Management with honors from the American Graduate School of International Management (Thunderbird); a MSc. in Biochemical Engineering from the University of London, University College London; and a BSc. in Biomedical Engineering from Tulane University, magna cum laude.
Sabrina currently serves on the boards of ATAI Life Sciences, a publicly-traded clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, and Aethlon Medical, Inc., a publicly-traded company developing immunotherapeutic technologies to combat infectious disease and cancer, BIOCOM, as Vice President of Industry, the Clearity Foundation as Chair, and the YWCA of San Diego County as Past President. Additionally, Sabrina serves on the Board of Advisors of Tulane University School of Science & Engineering and on the Audit Committee of Project Concern International.
Ms. Johnson was honored by Athena, a San Diego-based business organization championing women executives and rising managers in science, technology, engineering and mathematics, with the Individual in Life Science award in 2017 and the same year received the “Moxie” for her grit and determination and positive impact in the community from the award-winning MOXIE Theatre, a Southern California theatre dedicated to producing diverse and honest images of women using the art of theatre. She was an E&Y Entrepreneur of the Year San Diego finalist in 2018 and in 2019 was recognized as an entrepreneur in the PharmaVoice 100 and honored as 2019 Director of the Year in the Emerging Board Leader category by the San Diego Corporate Directors Forum.
Cyril Vancura
Cyril Vancura is Partner at imec.xpand, an independently managed value-add venture capital fund that focuses on hardware-based nanotechnology innovations where imec technology, expertise, network and infrastructure will play a differentiating role. Based in Leuven, Belgium, Cyril is focusing predominantly on deeptech investment opportunities in Europe and the US. Before joining imec.xpand, Cyril was Investment Principal at Robert Bosch Venture Capital GmbH (RBVC), the corporate venture arm of Robert Bosch GmbH. At RBVC he was based in Germany, as well as, in the affiliate office in Silicon Valley. Cyril holds a Ph.D. and a diploma (Master Degree) in physics from the Swiss Federal Institute of Technology (ETH) in Zurich, Switzerland.
Moshe Tanach
Dan McCreary
Dan is a distinguished engineer in AI working on innovative database architectures including document and graph databases. He has a strong background in semantics, ontologies, NLP and search. He is a hands-on architect and like to build his own pilot applications using new technologies. Dan started the NoSQL Now! Conference (now called the Database Now! Conferences). He also co-authored the book Making Sense of NoSQL, one of the highest rated books on Amazon on the topic of NoSQL. Dan worked at Bell Labs as a VLSI circuit designer where he worked with Brian Kernighan (of K&R C). Dan also worked with Steve Jobs at NeXT Computer.
Mattie Yeta
Dr Sam Hoste
Dr Sam Hoste, through Quantech Solutions, has undertaken Agri-Tech leadership roles in business, central government and global consultancy firms. He has led sector-wide animal health improvement initiatives; was instrumental in the establishment of the UK’s Agri-Tech Centres and COO of the Centre for Innovation Excellence in Livestock. He was a director and geneticist at ACMC and NPD, and UK Technical manager for PIC and a non-Exec at the Irish startup, Monford Ag. He is currently working with a number of UK and international Agri-tech companies that provide data, vision and emissions reduction opportunities for farmers and supply chains.
Phillip Harris
